These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12719660)

  • 1. Effects of chronic administration of zonisamide, an antiepileptic drug, on bone mineral density and their prevention with alfacalcidol in growing rats.
    Takahashi A; Onodera K; Kamei J; Sakurada S; Shinoda H; Miyazaki S; Saito T; Mayanagi H
    J Pharmacol Sci; 2003 Apr; 91(4):313-8. PubMed ID: 12719660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenytoin-induced bone loss and its prevention with alfacalcidol or calcitriol in growing rats.
    Onodera K; Takahashi A; Mayanagi H; Wakabayashi H; Kamei J; Shinoda H
    Calcif Tissue Int; 2001 Aug; 69(2):109-16. PubMed ID: 11683423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of combined administration of alfacalcidol and risedronate on cancellous and cortical bone mass of the tibia in glucocorticoid-treated young rats.
    Iwamoto J; Seki A; Takeda T; Yamada H; Sato Y; Yeh JK
    Chin J Physiol; 2008 Jun; 51(3):121-8. PubMed ID: 18935906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Greater efficacy of alfacalcidol in the red than in the yellow marrow skeletal sites in adult female rats.
    Tian XY; Liu XQ; Chen HY; Setterberg RB; Li M; Jee WS
    J Musculoskelet Neuronal Interact; 2008; 8(3):257-66. PubMed ID: 18799859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of alfacalcidol on cancellous and cortical bone mass in rats treated with glucocorticoid: a bone histomorphometry study.
    Iwamoto J; Seki A; Takeda T; Yamada H; Sato Y; Yeh JK
    J Nutr Sci Vitaminol (Tokyo); 2007 Jun; 53(3):191-7. PubMed ID: 17874822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of phenytoin and/or vitamin K2 (menatetrenone) on bone mineral density in the tibiae of growing rats.
    Onodera K; Takahashi A; Sakurada S; Okano Y
    Life Sci; 2002 Feb; 70(13):1533-42. PubMed ID: 11895104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the antiepileptics phenytoin and zonisamide on dentin formation and bone mineral density of the mandible in growing rats.
    Takahashi A; Saito T; Mayanagi H; Kamei J; Onodera K
    Methods Find Exp Clin Pharmacol; 2004 Dec; 26(10):769-73. PubMed ID: 15672119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of alendronate and alfacalcidol on cancellous and cortical bone mass and bone mechanical properties in ovariectomized rats.
    Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Yeh JK
    Exp Anim; 2006 Jul; 55(4):357-67. PubMed ID: 16880683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alfacalcidol prevents age-related bone loss and causes an atypical pattern of bone formation in aged male rats.
    Li M; Healy DR; Li Y; Simmons HA; Su M; Jee WS; Shen VW; Thompson DD
    J Musculoskelet Neuronal Interact; 2004 Mar; 4(1):22-32. PubMed ID: 15615075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive effect of vitamin K2 and risedronate on long bone mass in hypophysectomized young rats.
    Iwamoto J; Takeda T; Sato Y; Yeh JK
    Exp Anim; 2007 Apr; 56(2):103-10. PubMed ID: 17460355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative therapeutic effects of alendronate and alfacalcidol on cancellous and cortical bone mass and mechanical properties in ovariectomized osteopenic rats.
    Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Yeh JK
    J Nutr Sci Vitaminol (Tokyo); 2006 Feb; 52(1):1-8. PubMed ID: 16637224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alfacalcidol prevents aromatase inhibitor (Letrozole)-induced bone mineral loss in young growing female rats.
    Mohamed I; Yeh JK
    J Endocrinol; 2009 Aug; 202(2):317-25. PubMed ID: 19420010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of incadronate and alfacalcidol on increased bone turnover caused by ovariectomy in rats.
    Teramura K; Fukushima S; Nozaki K; Kokubo S; Takahashi K
    Eur J Pharmacol; 2002 Aug; 449(1-2):191-6. PubMed ID: 12163124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of risedronate on the cortical and cancellous bone mass and mechanical properties in ovariectomized rats: a comparison with the effects of alfacalcidol.
    Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Yeh JK
    J Nutr Sci Vitaminol (Tokyo); 2006 Dec; 52(6):393-401. PubMed ID: 17330501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of alendronate and alfacalcidol on the femoral bone mass and bone strength in orchidectomized rats.
    Iwamoto J; Matsumoto H; Takeda T; Sato Y; Xu E; Yeh JK
    Chin J Physiol; 2008 Dec; 51(6):331-7. PubMed ID: 19280876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ED-71, a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis.
    Uchiyama Y; Higuchi Y; Takeda S; Masaki T; Shira-Ishi A; Sato K; Kubodera N; Ikeda K; Ogata E
    Bone; 2002 Apr; 30(4):582-8. PubMed ID: 11934649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alfacalcidol increases cancellous bone in low turnover, fatty marrow sites in aged, orchidectomized rats.
    Tian XY; Chen HY; Setterberg RB; Li M; Jee WS
    J Musculoskelet Neuronal Interact; 2009; 9(3):138-46. PubMed ID: 19724148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium supplementation does not reproduce the pharmacological efficacy of alfacalcidol for the treatment of osteoporosis in rats.
    Shiraishi A; Ito M; Hayakawa N; Kubota N; Kubodera N; Ogata E
    Calcif Tissue Int; 2006 Mar; 78(3):152-61. PubMed ID: 16525749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alfacalcidol-stimulated focal bone formation on the cancellous surface and increased bone formation on the periosteal surface of the lumbar vertebrae of adult female rats.
    Chen H; Tian X; Liu X; Setterberg RB; Li M; Jee WS
    Calcif Tissue Int; 2008 Feb; 82(2):127-36. PubMed ID: 18175034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The advantage of alfacalcidol over vitamin D in the treatment of osteoporosis.
    Shiraishi A; Higashi S; Ohkawa H; Kubodera N; Hirasawa T; Ezawa I; Ikeda K; Ogata E
    Calcif Tissue Int; 1999 Oct; 65(4):311-6. PubMed ID: 10485984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.